12 w - Translate

https://www.selleckchem.com/pr....oducts/lanifibranor-
01 for each). OHNS expansion of US MD (  = .046), but not all applicants (  = .169), outgrew that of Neurosurgery. The 2020 to 2021 cycle affected by the COVID-19 pandemic saw a continuation of the recent trend in the expanding OHNS applicant pool. OHNS remains one of the specialties with the highest APP ratio and has observed a significant growth compared to PS since 2018. Understanding and anticipating trends in residency application cycles is critical for designing processes to optimize the best fit between applicants an